Articles with public access mandates - Gerhard GlattingLearn more
Not available anywhere: 28
Choosing the optimal fit function: comparison of the Akaike information criterion and the F‐test
G Glatting, P Kletting, SN Reske, K Hohl, C Ring
Medical physics 34 (11), 4285-4292, 2007
Mandates: German Research Foundation
Model selection for time-activity curves: the corrected Akaike information criterion and the F-test
P Kletting, G Glatting
Zeitschrift für medizinische Physik 19 (3), 200-206, 2009
Mandates: German Research Foundation
The role of patient-based treatment planning in peptide receptor radionuclide therapy
D Hardiansyah, C Maass, AA Attarwala, B Müller, P Kletting, FM Mottaghy, ...
European journal of nuclear medicine and molecular imaging 43, 871-880, 2016
Mandates: German Research Foundation
Comparing time activity curves using the Akaike information criterion
P Kletting, T Kull, SN Reske, G Glatting
Physics in Medicine & Biology 54 (21), N501, 2009
Mandates: German Research Foundation
Treatment planning algorithm for peptide receptor radionuclide therapy considering multiple tumor lesions and organs at risk
LD Jiménez‐Franco, P Kletting, AJ Beer, G Glatting
Medical physics 45 (8), 3516-3523, 2018
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Comparison of five cluster validity indices performance in brain [18F]FET‐PET image segmentation using k‐means
B Abualhaj, G Weng, M Ong, AA Attarwala, F Molina, K Büsing, G Glatting
Medical physics 44 (1), 209-220, 2017
Mandates: Federal Ministry of Education and Research, Germany
Optimal preloading in radioimmunotherapy with anti‐CD45 antibody
P Kletting, T Kull, D Bunjes, M Luster, SN Reske, G Glatting
Medical physics 38 (5), 2572-2578, 2011
Mandates: German Research Foundation
Internal radionuclide therapy
G Glatting, M Landmann, A Wunderlich, T Kull, FM Mottaghy, SN Reske
Nuklearmedizin-NuclearMedicine 45 (06), 269-272, 2006
Mandates: German Research Foundation
Dosimetry with 188Re-labelled monoclonal anti-CD66 antibodies
G Glatting, T Kull, NM Blumstein, D Bunjes, B Neumaier, AK Buck, ...
Nuklearmedizin-NuclearMedicine 45 (03), 134-138, 2006
Mandates: German Research Foundation
Short Communication: 18F-Immuno-PET: Determination of Anti-CD66 Biodistribution in a Patient with High-Risk Leukemia
B Neumaier, FM Mottaghy, AK Buck, G Glatting, NM Blumstein, B Mahren, ...
Cancer biotherapy & radiopharmaceuticals 23 (6), 819-824, 2008
Mandates: German Research Foundation
Treatment planning in PRRT based on simulated PET data and a PBPK model
D Hardiansyah, W Guo, AA Attarwala, P Kletting, FM Mottaghy, G Glatting
Nuklearmedizin-NuclearMedicine 56 (01), 23-30, 2017
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
A simulation-based method to determine optimal sampling schedules for dosimetry in radioligand therapy
A Rinscheid, J Lee, P Kletting, AJ Beer, G Glatting
Zeitschrift für Medizinische Physik 29 (4), 314-325, 2019
Mandates: German Research Foundation
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands
G Winter, A Vogt, LD Jiménez-Franco, A Rinscheid, ...
Nuclear Medicine and Biology 72, 20-25, 2019
Mandates: German Research Foundation
Investigation of the imaging characteristics of the ALBIRA II small animal PET system for 18F, 68Ga and 64Cu
AA Attarwala, YW Karanja, D Hardiansyah, C Romano, M Roscher, ...
Zeitschrift für Medizinische Physik 27 (2), 132-144, 2017
Mandates: Federal Ministry of Education and Research, Germany
Population-Based Modeling Improves Treatment Planning Before 90Y-Labeled Anti-CD66 Antibody Radioimmunotherapy
C Maaß, P Kletting, D Bunjes, B Mahren, AJ Beer, G Glatting
Cancer Biotherapy and Radiopharmaceuticals 30 (7), 285-290, 2015
Mandates: German Research Foundation
Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: A simulation study
P Kletting, SN Reske, G Glatting
Zeitschrift für Medizinische Physik 21 (4), 301-304, 2011
Mandates: German Research Foundation
Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistribution
FJ Kiraly, P Kletting, SN Reske, G Glatting
Nuklearmedizin-NuclearMedicine 48 (03), 113-119, 2009
Mandates: German Research Foundation
Determination of the immunoreactivity of radiolabeled monoclonal antibodies: A theoretical analysis
G Glatting, SN Reske
Cancer biotherapy & radiopharmaceuticals 21 (1), 15-21, 2006
Mandates: German Research Foundation
A method for point spread function estimation for accurate quantitative imaging
AA Attarwala, D Hardiansyah, C Romano, M Roscher, F Molina-Duran, ...
IEEE Transactions on Nuclear Science 65 (3), 961-969, 2018
Mandates: Federal Ministry of Education and Research, Germany
Determination of individual organ masses for 90Y-anti-CD66 radioimmunotherapy: Influence on therapy planning
T Kull, P Kletting, SN Reske, G Glatting
Zeitschrift für Medizinische Physik 21 (4), 305-309, 2011
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program